Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 43 (PPIAP43)

Target
PPIAP43
Molecular classification
Other (Pseudogene/Long non-coding RNA)
01

Overview

Peptidylprolyl isomerase A pseudogene 43 (PPIAP43) is a pseudogene transcribed as a long non-coding RNA that shares substantial sequence similarity with the peptidylprolyl isomerase A (PPIA) gene. Unlike protein-coding genes, PPIAP43 does not encode a functional protein but instead produces RNA transcripts that can act as decoys for microRNAs targeting PPIA, thereby indirectly regulating PPIA levels. In the context of small cell lung cancer, transcription of PPIAP43 is upregulated in response to ionizing radiation in radiation-sensitive cell lines, suggesting its value as a biomarker to differentiate responsive from non-responsive tumors. Its primary biological function appears to be RNA-level post-transcriptional regulation rather than acting as a traditional therapeutic target. There are no known drug interactions or direct mechanisms of action attributed to PPIAP43, as it does not produce a protein product nor serve as an enzyme, receptor, or transporter. PPIAP43 itself is not a therapeutic target, but rather a non-coding RNA with potential roles in gene regulation and as a biomarker. The function and disease association of PPIAP43 are generally inferred by its regulatory relationship with its parental gene PPIA (cyclophilin A), which is involved in wider physiological and pathological processes, but the pseudogene is distinct and does not encode a protein. Some information may confuse PPIAP43 with its parental gene PPIA; it is crucial to distinguish these, as PPIA (protein) is a validated drug target, while PPIAP43 (pseudogene/non-coding RNA) is not.

Other names
Peptidyl-prolyl cis-trans isomerase A pseudogene 43PPIA pseudogene 43
02

Biological functions

Competing endogenous RNAMicroRNA sponge (decoy)Regulation of parental gene (PPIA) expression
03

Disease associations

Potential biomarker (radiation sensitivity in small cell lung cancer)Possible involvement (via parental gene PPIA) in cancer biology
04

Biomarkers

Biomarker for radiation sensitivity in small cell lung cancer

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 43 (PPIAP43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 43 (PPIAP43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call